These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16918966)

  • 1. Author's response: medical or surgical decompression of optic neuropathy in Graves' ophthalmopathy: the choice remains unclear.
    Wakelkamp IM; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):408. PubMed ID: 16918966
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical or surgical decompression of optic neuropathy in Graves' ophthalmopathy: the choice remains unclear.
    Kapamajian MA
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):132. PubMed ID: 16817832
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Bartalena L
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcaruncular orbital decompression: an alternative procedure for graves ophthalmopathy with compressive optic neuropathy.
    Bernardino CR; Chang EL; Rubin PA
    Am J Ophthalmol; 2006 Oct; 142(4):711-2; author reply 712-3. PubMed ID: 17011891
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
    Tang IP; Prepageran N; Subrayan V; Tajunisah I
    Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic orbital and optic nerve decompression.
    Metson R; Pletcher SD
    Otolaryngol Clin North Am; 2006 Jun; 39(3):551-61, ix. PubMed ID: 16757231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe Graves' ophthalmopathy accompanied by myasthenia gravis].
    Maeda K; Kume S; Nishio Y; Maeda S; Nishida Y; Suzuki M; Nakaguchi T; Kawabata T; Hashimoto O; Hisanaga T; Kashiwagi A; Yasuda H
    Rinsho Shinkeigaku; 2006 Apr; 46(4):266-9. PubMed ID: 16768093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraorbital pressure measured before, during, and after surgical decompression in Graves' orbitopathy].
    Berthout A; Vignal C; Jacomet PV; Galatoire O; Morax S
    J Fr Ophtalmol; 2010 Nov; 33(9):623-9. PubMed ID: 21047700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of Graves' ophthalmopathy].
    Schalin-Jäntti C
    Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Drs Litwin and Malhotra.
    Verity DH; Rose GE
    Eye (Lond); 2014 May; 28(5):632-3. PubMed ID: 24603427
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcaruncular orbital decompression: an alternate procedure for graves ophthalmopathy with compressive optic neuropathy.
    Perry JD
    Am J Ophthalmol; 2006 Nov; 142(5):889; author reply 889-90. PubMed ID: 17056385
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'.
    Litwin AS; Malhotra R
    Eye (Lond); 2014 May; 28(5):632. PubMed ID: 24603423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic orbital and optic nerve decompression.
    Pletcher SD; Sindwani R; Metson R
    Otolaryngol Clin North Am; 2006 Oct; 39(5):943-58, vi. PubMed ID: 16982256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment by rituximab on six Grave's ophthalmopathies resistant to corticosteroids.
    Précausta F; Arsène S; Renoult-Pierre P; Laure B; Crinière L; Pisella PJ
    Ann Endocrinol (Paris); 2017 Feb; 78(1):20-26. PubMed ID: 28185649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.